Medicinal Products

Keytruda

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Keytruda
Active Substance pembrolizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC18
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for patients / caregivers
Knjižica za bolesnika, verzija 7
Kartica s upozorenjima za bolesnika, verzija 7

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o ograničenju indikacije lijeka Keytruda (pembrolizumab) 10.07.2018 Merck Sharp & Dohme B. V.
Back